Amble Tirzepatide is a high purity dual GIP and GLP-1 receptor agonist peptide with CAS number 2023788-19-2. This pharmaceutical grade compound has shown significant potential in diabetes research applications.
The product is supplied as a white lyophilized powder with 99% purity, packaged in sterile vials. Amble Tirzepatide has demonstrated superior efficacy in glucose control and weight management compared to similar compounds in research settings.
Available in multiple concentrations (2mg, 5mg, and 10mg per vial) to meet various research requirements. Each order includes comprehensive analytical documentation to verify product quality and specifications.
Amble Tirzepatide (LY3298176) represents an important advancement in peptide research, particularly for metabolic disorder studies. The product is strictly for laboratory research use only.